Clinical Trial Update: Effects of Acute and Chronic Empagliflozin Heart Failure [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial led by Yale University is evaluating the acute and chronic effects of empagliflozin in heart failure and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Jardiance (empagliflozin)

Snippet

Sponsor: Yale University | Conditions: Heart Failure | Phase 1 | Status: RECRUITING